← All diseases
Cancer
Lung cancer (small cell)
Do you want to receive a message when there is new research about Small Cell Lung Cancer (SCLC)? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above every publication you see one sentence explaining what was studied — and you'll be notified as soon as there is new research about Small cell lung cancer. View what Premium costs.
Publications and studies (3295)
- Frequency of weight and body composition increases in advanced non-small cell lung cancer patients during first line therapy. (2024/12/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Body composition derangements in lung cancer patients treated with first-line pembrolizumab: A multicentre observational study. (2024/12/01) ♡
- [Correction: Improving the nutritional situation of patients with advanced non-small cell lung cancer (NSCLC) through off-label medication]. (2024/12/01) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. The prognostic significance of diabetes in non-small cell lung cancer patients treated with immune checkpoint inhibitors: A meta-analysis. (2024/12/01) ♡
- Clinical impact of preoperative sarcopenia and immunonutritional impairment on postoperative outcomes in non-small cell lung cancer surgery. (2024/12/01) ♡
- Phosphorylase kinase regulatory subunit alpha 1 as a novel biomarker involved in development and progression of lung cancer: comprehensive bioinformatic analysis and experiment validation. (2024/12/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [A Case of Postoperative Recurrence of Sigmoid Colon Cancer That Was Diagnosed as a Result of Cervical and Mediastinal Lymph Node Metastasis]. (2024/12/01) ♡
- The preoperative hemoglobin, albumin, lymphocyte, and platelet score (HALP) as a prognostic indicator in patients with non-small cell lung cancer. (2024/11/28) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Traditional Chinese medicine and its components effectively reduce resistance mediated by immune checkpoint inhibitors. (2024/11/26) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Association between the dietary inflammatory index and risk of lung cancer: a multi-centered case-control study. (2024/11/26) ♡
- Unraveling impact and potential mechanisms of baseline pain on efficacy of immunotherapy in lung cancer patients: a retrospective and bioinformatic analysis. (2024/11/25) ♡
- Pulmonary artery enlargement as a predictor of long-term prognosis in patients with resected early-stage non-small cell lung cancer. (2024/11/23) ♡
- B-Lightning: using bait genes for marker gene hunting in single-cell data with complex heterogeneity. (2024/11/22) ♡
- Should Radiation Dose Be Personalized in Patients With Localized NSCLC and Actionable Genetic Alterations? Insight From a Multicenter Real-World Study. (2024/11/22) ♡
- Three-dimensional virtual lung reconstruction in robotic segmentectomy: A safety and feasibility trial. (2024/11/20) ♡
- Prognostic Role of Inflammatory and Nutritional Biomarkers in Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors Alone or in Combination with Chemotherapy as First-Line. (2024/11/19) ♡
- Using Nurse Navigators to Improve Timeliness of Biomarker Testing for Non-Small Cell Lung Cancer. (2024/11/19) ♡
- Cutaneous Toxicities With Amivantamab for Non-Small Cell Lung Cancer: A Practical Guide and Best Practices. (2024/11/19) ♡
- National race and socioeconomic disparities in access to minimally invasive lung resection for early-stage lung cancer: Impact on mortality. (2024/11/19) ♡
- Clinical significance of visual cardiac (18) F-FDG uptake in advanced non-small cell lung cancer. (2024/11/18) ♡
- Targeting ErBb and tankyrase1/2 prevent the emergence of drug-tolerant persister cells in ALK-positive lung cancer. (2024/11/17) ♡
- Mechanistic insights into Yifei Sanjie pill's regulation of EMT to enhance gefitinib treatment effect in NSCLC by in silico analysis and experimental validation. (2024/11/15) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Advances in clinical trials on perioperative immune checkpoint inhibitors for resectable non-small cell lung cancer: A comprehensive review. (2024/11/15) ♡
- The role and mechanism of “eight famous herbals in Zhejiang” in cancer via network pharmacology and experimental validation. (2024/11/15) ♡
- Dosimetric Predictors of Acute Radiation Pneumonitis and Esophagitis in Hypofractionated Thoracic Irradiation of Non-Small Cell Lung Cancer Patients With Poor Prognostic Factors. (2024/11/15) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Revolutionizing Cancer Immunotherapy: Emerging Nanotechnology-Driven Drug Delivery Systems for Enhanced Therapeutic Efficacy. (2024/11/15) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Dietary pattern and the corresponding gut microbiome in response to immunotherapy in Thai patients with advanced non-small cell lung cancer (NSCLC). (2024/11/13) ♡
- Molecular Interactions of the Plant Steroid Hormone Epibrassinolide on Human Drug-Sensitive and Drug-Resistant Small-Cell Lung Carcinoma Cells. (2024/11/13) ♡
- Associations Between Patient-Reported Nutritional Status, Toxicity, and Survival in Limited-Stage SCLC. (2024/11/12) ♡
- Clinical Significance of Perioperative Minimal Residual Disease Detected by Circulating Tumor DNA in Patients With Lung Cancer With a Long Follow-up Data: An Exploratory Study. (2024/11/12) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Fantastic Frogs and Where to Use Them: Unveiling the Hidden Cinobufagin's Promise in Combating Lung Cancer Development and Progression Through a Systematic Review of Preclinical Evidence. (2024/11/07) ♡
- Potential COVID-19 remedies from repurposed drugs and herbal small RNAs. (2024/11/01) ♡
- Network Pharmacology Based Elucidation of Molecular Mechanisms of Lake Formula for Treatment of Advanced Non-Small Cell Lung Cancer. (2024/11/01) ♡
- COX-2/PTGS2-targeted herbal-derived oligonucleotide drug hQi-sRNA-2 was effective in the spontaneous mouse lung cancer model. (2024/11/01) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Patient-Reported Outcomes of Postoperative NSCLC Patients with or without Staged Chinese Herb Medicine Therapy during Adjuvant Chemotherapy (NALLC 2): A Randomized, Double-Blind, Placebo-Controlled Trial. (2024/11/01) ♡
- Shenqifuzheng injection inhibits lactic acid-induced cisplatin resistance in NSCLC by affecting FBXO22/p53 axis through FOXO3. (2024/11/01) ♡
- [Improving the nutritional situation of patients with advanced non-small cell lung cancer (NSCLC) through off-label medication]. (2024/11/01) ♡
- Oral Microbiome and Subsequent Risk of Head and Neck Squamous Cell Cancer. (2024/11/01) ♡
- A systematic evaluation of quenching, extraction and analysis procedures for metabolomics study of the mechanism of QYSLD intervention in A549 cells. (2024/11/01) ♡
- Comparison of Prognostic Values of Seven Immune Indexes in Advanced Non-Small-Cell Lung Cancer Treated with Nivolumab: How Effective Can They Be Regarding Our Treatment Decisions? (2024/11/01) ♡
- Overcoming multi-drug resistance in SCLC: a synergistic approach with venetoclax and hydroxychloroquine targeting the lncRNA LYPLAL1-DT/BCL2/BECN1 pathway. (2024/10/31) ♡
- Does the impact of medical publications vary by disease indication and publication type? An exploration using a novel, value-based, publication metric framework: the EMPIRE Index. (2024/10/30) ♡
- Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Prognostic Nutritional Index as Prognostic Markers for Lung Carcinoma. (2024/10/30) ♡
- The influence of magnesium and manganese cations on the chemical and bioactive properties of purple and green basil. (2024/10/28) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Postoperative chylothorax following video-assisted mediastinoscopic lymphadenectomy (VAMLA) for early-stage non-small cell lung carcinoma. (2024/10/28) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. In vitro study of a siRNA delivery liposome constructed with an ionizable cationic lipid. (2024/10/28) ♡
- Comprehensive analysis of single-cell transcriptomics and genetic factors reveals the mechanisms and preventive strategies for the progression from pulmonary fibrosis to lung cancer. (2024/10/25) ♡
- Effect of fermentation on the constituents in the branches and leaves of Taxus media and non-small cell lung cancer. (2024/10/23) ♡
- Adherence to lifelines diet is associated with lower lung cancer risk in 98,459 participants aged 55 years and above: a large prospective cohort study. (2024/10/23) ♡
- Germline Human Leukocyte Antigen Status is Associated With Immunotherapy-Induced Pneumonitis and Treatment Response in Patients With Non-Small Cell Lung Cancer With High Programmed Death-Ligand 1 Expression. (2024/10/23) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.